ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

ClinicalTrials.gov ID: NCT06549595

Public ClinicalTrials.gov record NCT06549595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 11:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 Plus Rituximab Versus Chemotherapy Plus Rituximab in Previously Untreated Participants With Follicular Lymphoma (SOUNDTRACK-F1)

Study identification

NCT ID
NCT06549595
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,018 participants

Conditions and interventions

Interventions

  • BR Drug
  • R-CHOP Drug
  • R-CVP Drug
  • Surovatamig Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 6, 2024
Primary completion
Nov 25, 2031
Completion
Nov 25, 2031
Last update posted
Apr 16, 2026

2024 – 2031

United States locations

U.S. sites
32
U.S. states
21
U.S. cities
30
Facility City State ZIP Site status
Research Site Anchorage Alaska 99508 Not yet recruiting
Research Site Phoenix Arizona 85054 Not yet recruiting
Research Site Clovis California 93611 Not yet recruiting
Research Site Los Alamitos California 90720 Not yet recruiting
Research Site San Diego California 92121 Not yet recruiting
Research Site Santa Monica California 90404 Not yet recruiting
Research Site Aurora Colorado 80045 Withdrawn
Research Site New Haven Connecticut 06510 Not yet recruiting
Research Site Jacksonville Florida 32224 Not yet recruiting
Research Site Atlanta Georgia 30322 Not yet recruiting
Research Site Macon Georgia 31201 Not yet recruiting
Research Site Fort Wayne Indiana 46804 Not yet recruiting
Research Site Des Moines Iowa 50309 Not yet recruiting
Research Site Iowa City Iowa 52242 Not yet recruiting
Research Site Louisville Kentucky 40207 Not yet recruiting
Research Site Baltimore Maryland 21201 Not yet recruiting
Research Site Bethesda Maryland 20817 Not yet recruiting
Research Site Boston Massachusetts 02215 Not yet recruiting
Research Site Ann Arbor Michigan 48109 Not yet recruiting
Research Site Detroit Michigan 48201 Not yet recruiting
Research Site Ypsilanti Michigan 48197 Not yet recruiting
Research Site Springfield Missouri 65807 Not yet recruiting
Research Site New Brunswick New Jersey 08901 Not yet recruiting
Research Site New Hyde Park New York 11042 Not yet recruiting
Research Site New York New York 10016 Not yet recruiting
Research Site New York New York 10032 Not yet recruiting
Research Site New York New York 10065 Not yet recruiting
Research Site Columbus Ohio 43210 Not yet recruiting
Research Site Pittsburgh Pennsylvania 15232 Not yet recruiting
Research Site Nashville Tennessee 37203 Not yet recruiting
Research Site Tacoma Washington 98405 Not yet recruiting
Research Site Madison Wisconsin 53792 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06549595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06549595 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →